Follow-up Study Clinical Trial
— RECALL-CTOfficial title:
A Randomised Controlled Trial of an Integrated Post-discharge Transitional Care Package for General Medical In-patients in Cape Town, South Africa
Verified date | December 2014 |
Source | University of Cape Town |
Contact | n/a |
Is FDA regulated | No |
Health authority | South Africa: Human Research Ethics Committee |
Study type | Interventional |
The post discharge time is a vulnerable time for general medical in-patients, with high
rates of adverse events that may cause unnecessary readmissions and even death. A recent
study of 415 patients discharged from the general medical wards at Groote Schuur Hospital,
demonstrated a very high 12 month mortality of 35%. The majority of these deaths were
classified as "unexpected". The reasons for this were not further examined, but it was
speculated, given the authors' knowledge of the public sector in Cape Town, that three
related factors contribute significantly to this early mortality: i) a lack of continuity of
care, with patients not necessarily accessing the primary care support treatment that they
need or being able to access early post discharge follow-up (for example for anti-retroviral
or anti-tuberculous care); ii) the inability of primary care to deal with the complex nature
of the discharged patients, most whom have significant co-morbid disease; iii) A lack of
optimisation of therapy for chronic disease after acute discharge.
The investigators hypothesise that an integrated post-discharge transitional care package,
which includes an early medical specialist follow-up in the first 3 months after hospital
discharge will decrease the 6- and 12-month mortality and re-admission rate amongst general
medical hospital admissions in Cape Town, South Africa. Our study will compare an integrated
package, suitable to implementation if effective, with current standard discharge packages.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | May 2016 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Patients referred for admission to general medical wards (including within hospital transfer e.g. ICU discharge) 2. >18 years and willing to give informed consent Exclusion Criteria: 1. Patient admitted directly to intensive care unit 2. Patient refusing consent or <18 years old 3. Patients electively admitted 4. Patients without phone numbers who cannot provide any telephone contact details for a co-habitant, relative or neighbour. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
South Africa | Groote Schuur Hospital | Cape Town | |
South Africa | Victoria Hospital | Cape Town |
Lead Sponsor | Collaborator |
---|---|
University of Cape Town |
South Africa,
Stuart-Clark H, Vorajee N, Zuma S, Van Niekerk L, Burch V, Raubenheimer P, Peter JG. Twelve-month outcomes of patients admitted to the acute general medical service at Groote Schuur Hospital. S Afr Med J. 2012 May 23;102(6):549-53. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | All cause mortality | All cause 12-month mortality will be evaluated at 12-months post enrolment. Data on mortality will be acquired through telephonic patient/family contact and review of provincial death registry | 12 months | No |
Secondary | All cause mortality | 6-month mortality will be evaluated in a similar way to 12-month mortality. | 6 months | No |
Secondary | Hospital readmission rate | Readmission to secondary, tertiary hospitals or emergency units will be included. | 12 months | No |
Secondary | Bartel index | The change in functional outcome between discharge and 12-months will be measured using the Bartel index. | 12 months | No |
Secondary | Karnofsky performance score | Changes in functional outcomes will be assessed by measuring the change in Karnofsky performance scores between 12-months and pre-admission. | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04542174 -
PMCF 8 Year Results TRJ®
|
||
Recruiting |
NCT04115137 -
Pelvic Varicose Veins Treated With Vascular Plugs Type Amplatzer: REPiVAC
|